The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution
Open accessPublished version of a preprint
Abstract
Pancreatic ductal adenocarcinoma (PDA) is a major cause of cancer-related death, with limited therapeutic options available. This highlights the need for improved understanding of the biology of PDA progression, a highly complex and dynamic process, featuring changes in cancer cells and stromal cells. A comprehensive characterization of PDA cancer cell and stromal cell heterogeneity during disease progression is lacking. In this study, we aimed to profile cell populations and understand their phenotypic changes during PDA progression. To that end, we used single-cell RNA–sequencing technology to agnostically profile cell heterogeneity during different stages of PDA progression in genetically engineered mouse models. Our data indicate that an epithelial-mesenchymal transition of cancer cells accompanies tumor progression in addition to distinct populations of macrophages with increasing inflammatory features. We also noted the existence of 3 distinct molecular subtypes of fibroblasts in the normal mouse pancreas, which ultimately gave rise to 2 distinct populations of fibroblasts in advanced PDA, supporting recent reports on intratumor fibroblast heterogeneity. Our data also suggest that cancer cells and fibroblasts may be dynamically regulated by epigenetic mechanisms. This study systematically describes the landscape of cellular heterogeneity during the progression of PDA and has the potential to act as a resource in the development of therapeutic strategies against specific cell populations of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The data gained through this approach suggests neoadjuvant treated patients would potentially respond better to adjuvant immunotherapy.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [268]
In the citing paper
“Illustrating this, a 36 marker CyTOF characterization of peripheral blood from PDAC patients revealed neoadjuvant FOLFIRINOX promotes an increase in effector T cells and concurrent decrease in suppressive immune populations268.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [268]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Massively parallel digital transcriptional profiling of single cells
Zheng, G. X. Y., Terry, J. M., Belgrader, P., Ryvkin, P., Bent, Z. W., Wilson, R., Ziraldo, S. B., Wheeler, T. D., McDermott, G. P., Zhu, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14049 · Cited by 7,353
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Super-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Self-citationHingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Self-citation
Cited by
Sorted by citations
Items 201–296 of 296
Juan, C., & Peng, Y. S. (2025) · Cancers · doi:10.3390/cancers17244003 · Cited by 8
Cho, S. J., Oh, J., Baek, J., Shin, Y., Kim, W., Ko, J., Jun, E., Lee, D., Kim, S., Sohn, I., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40957-1 · Cited by 8
Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy
Sun, W., Xie, S., Liu, S., Hu, X., & Xing, D. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s453265 · Cited by 8
The application of single-cell sequencing in pancreatic neoplasm: analysis, diagnosis and treatment
Lv, G., Zhang, L., Gao, L., Cui, J., Liu, Z., Sun, B., Wang, G., & Tang, Q. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02023-x · Cited by 8
Mejia, I., Bodapati, S., Chen, K. T., & Díaz, B. (2020) · Biomedicines · doi:10.3390/biomedicines8100401 · Cited by 9
Kinny‐Köster, B., Guinn, S. R., Tandurella, J. A., Mitchell, J. T., Sidiropoulos, D. N., Loth, M., Lyman, M. R., Pucsek, A. B., Seppälä, T. T., Cherry, C., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.14.500096 · Cited by 10
CFTR represses a PDX1 axis to govern pancreatic ductal cell fate
Rotti, P. G., Yi, Y., Gasser, G. N., Yuan, F., Sun, X., Evans, I. A., Wu, P., Liu, G., Choi, S. H., Reeves, R. E., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111393 · Cited by 7
Seidel, T., Ohri, N., Glaß, M., Sunami, Y., Müller, L. P., & Kleeff, J. H. (2025) · Cancers · doi:10.3390/cancers17091541 · Cited by 7
Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer
Wang, X., Shinjo, K., Kumegawa, K., Maruyama, R., Mii, S., Shiraki, Y., Nishimura, T., Murofushi, Y., Suzuki, M., Kabasawa, T., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03299-5 · Cited by 7
A stromal PAI1-tPA axis orchestrates immunosuppression in pancreatic cancer
Ngodup, T., Elson, B. E., Mello, A. M., Hannifin, S., Liu, M., Zhang, Y., Shi, J., Shah, Y. M., Lawrence, D. A., di Magliano, M. P., et al. (2026) · Science Advances · doi:10.1126/sciadv.aea6734 · Cited by 7
ID1 marks the tumorigenesis of pancreatic ductal adenocarcinoma in mouse and human
Tang, Y., Zhang, S., Li, J., Wu, C., & Fan, Q. (2022) · Scientific Reports · doi:10.1038/s41598-022-17827-3 · Cited by 7
Erreni, M., Fumagalli, M. R., D’Anna, R., Sollai, M., Bozzarelli, S., Nappo, G., Zanini, D., Parente, R., Garlanda, C., Rimassa, L., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1472433 · Cited by 7
Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote Tumorigenesis
Castro-Pando, S., Howell, R. M., Li, L., Mascaró, M., Faraoni, E. Y., Roux, O. L., Romanin, D., Tahan, V., Riquelme, E. M., Zhang, Y., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0527 · Cited by 7
Clonal Heterogeneity Supports Mitochondrial Metabolism in Pancreatic CancerPreprint
Halbrook, C. J., Thurston, G., McCarthy, A., Nelson, B. S., Sajjakulnukit, P., Krall, A. S., Mullen, P. J., Zhang, L., Batra, S., Viale, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.15.098368 · Cited by 7
Determinants, mechanisms, and functional outcomes of myeloid cell diversity in cancer
Caronni, N., Montaldo, E., Mezzanzanica, L., Cilenti, F., Genua, M., & Ostuni, R. (2021) · Immunological Reviews · doi:10.1111/imr.12944 · Cited by 6
CAFomics: convergence to translation for precision stroma approaches
McCabe, I. C., Peng, X. L., Kearney, J. F., & Yeh, J. J. (2024) · Carcinogenesis · doi:10.1093/carcin/bgae063 · Cited by 6
Type 2 diabetes alters quiescent pancreatic stellate cells to tumor-prone state
Hara, Y., Mizukami, H., Yamada, T., Shimoyama, S., Yamazaki, K., Sasaki, T., Wang, Z., Kushibiki, H., Ryuzaki, M., Ogasawara, S., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.187424 · Cited by 6
Self-citationTang, L., Zhang, L. R., Yao, S., Li, X., Wang, Y., Liu, Q., Li, J., Wen, G., An, J., Jin, H., et al. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5579 · Cited by 6
Xin, S., Zhang, Y., Zhang, Z., Li, Z., Sun, X., Liu, X., Jin, L., Li, W., Tang, C., Mei, W., et al. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00779-3 · Cited by 6
Ijichi, H. (2022) · Cancers · doi:10.3390/cancers14194880 · Cited by 6
Geostatistical Modeling and Heterogeneity Analysis of Tumor Molecular Landscape
Hajihosseini, M., Amini, P., Voicu, D., Dinu, I. A., & Pyne, S. (2022) · Cancers · doi:10.3390/cancers14215235 · Cited by 6
Tracing the Origin of Fibroblasts in Pancreatic Cancer
Biffi, G. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.06.008 · Cited by 6
Hannifin, S., Mello, A. M., Ngodup, T., Kim, N. H., di Magliano, M. P., & Lee, K. E. (2026) · Cells · doi:10.3390/cells15080683 · Cited by 5
Amini, P., Hajihosseini, M., Pyne, S., & Dinu, I. A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1065586 · Cited by 5
Tumor cell-intrinsic epigenetic SETpoint of cancer-associated fibroblasts
Chen, X., & Huang, H. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.001 · Cited by 5
Self-citationGriffith, B. D., Kadiyala, P., McGue, J. J., Sun, L., Kumar, A., Espinoza, C. E., Donahue, K. L., Iyer, M. K., Speyer, C. B., Nelson, S., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-0377 · Cited by 5
KRAS Inhibition Activates an Actionable CD24 “Do Not Eat Me” Signal in Pancreatic Cancer
Wei, Y., Liu, M., Yen, E.-Y., Yao, J., Xun, Z., Nguyen, P. T.-M., Wang, X., Yang, Z., Yousef, A. M. G., Pan, D. N., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-2024 · Cited by 5
Boeker, V., Wilke, L., Mansourkiaei, A., Le, V. M. H., Church, K. A., Czigány, Z., Kong, B., Kugeratski, F. G., Kleeff, J. H., Weitz, J., et al. (2025) · BJC Reports · doi:10.1038/s44276-025-00150-5 · Cited by 4
Sun, H., Gao, M., Liu, Z., Zg, Z., Li, X., Huang, H., Li, T., Shi, J., Yan, J., Sun, M., et al. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01293-5 · Cited by 4
Self-citationKhan, T. B., Choudhary, N., Sharma, S., Kumar, D., Kaushik, U., Gupta, V., Gowri, S., Faiyazuddin, M., & Webster, T. J. (2026) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2026.100188 · Cited by 4
ATM Deficiency Induces TGFβ-Mediated Stromal Programming in Pancreatic Cancer
Roger, É., Mummey, H. M., Zimmer, E., Srinivasan, D., Härle, A., Moubri, L., Michels, A. K., Singh, R., Ekizce, M., Melzer, M. K., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-26-0138 · Cited by 4
Tumor-Fibroblast Interactions in Carcinomas
Dongre, H., & Costea, D. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_7 · Cited by 4
Chang, J., Lo, Z. H. Y., Alenizi, S., & Kovačević, Ž. (2023) · Cancers · doi:10.3390/cancers15102779 · Cited by 5
Sun, X., Yang, D., & Chen, Y. (2023) · Cells · doi:10.3390/cells12222614 · Cited by 4
Søland, T. M., Lipka, A., Ruus, A., Molværsmyr, A.-K., Galtung, H. K., & Haug, T. M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1456346 · Cited by 4
Wang, R., Liu, J., Jiang, B., Gao, B., Luo, H., Yang, F., Ye, Y., Chen, Z., Liu, H. S., Cui, C., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1454833 · Cited by 4
Bowman, C. L., Daniel, C. J., Carlson, E. J., Shah, V. M., Farrell, A. S., Kresse, K. M., Wang, X., Lindley, K. A., Kuhn, M. R., Hawthorne, K., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3437 · Cited by 6
Tamaddon, M., Azimzadeh, M., Gifani, P., & Tavangar, S. M. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1029758 · Cited by 3
Ji, Y., Xu, Q., & Wang, W. (2024) · PeerJ · doi:10.7717/peerj.17350 · Cited by 3
Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics
Layeghi‐Ghalehsoukhteh, S., Choudhuri, S. P., Ocal, O., Zolghadri, Y., Pashkov, V., Niederstrasser, H., Posner, B. A., Kantheti, H. S., Azevedo‐Pouly, A. C. P., Huang, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77373-8 · Cited by 3
Self-citationSignificance of Tumor Microenvironment for Regulating Pancreatic Cancer
Ijichi, H. (2023) · Cancers · doi:10.3390/cancers15092482 · Cited by 3
Netrin G1 Ligand is a new stromal immunomodulator that promotes pancreatic cancerPreprint
Costa, D. B. V., Francescone, R., Franco‐Barraza, J., Luong, T., Graves, M., de Aquino, A. M., Steele, N. G., Gardiner, J. C., dos Santos, S. A. A., Ogier, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.15.594354 · Cited by 3
Genomic landscapes and therapeutic perspectives of cancer stem cells in the tumor microenvironment
Shrestha, P., Lee, D., Giri, A., Thi, T.-H. L., & Yook, S. (2025) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-025-00794-y · Cited by 2
Cancer-Associated Fibroblasts: Heterogeneity and Bimodality in Oncogenesis
Lunina, N. A., Safina, D. R., & Kostrov, S. V. (2023) · Molecular Biology · doi:10.31857/s0026898423050105 · Cited by 2
Liu, Z., Zhang, Y., & Wu, C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115664 · Cited by 2
Gao, H., Yin, J., Guan, X., Zhang, S., Peng, S., Liu, X., & Xing, F. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-023-01235-5 · Cited by 2
Phenotype-guided subpopulation identification from single-cell sequencing dataPreprint
Sun, D., Guan, X., Moran, A. E., Qian, D. Z., Schedin, P. S., Dai, M., Danilov, A., Alumkal, J., Adey, A., Spellman, P. T., et al. (2020) · Research Square · doi:10.1101/2020.06.05.137240 · Cited by 2
Wu, S., Amin, S., Lee, C., Richard, J.-B., Merali, N., Morrell, C., Overend, L., Gao, W., Tucci, F., Gordon-Weeks, A. N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.30.662328 · Cited by 2
Liu, H., Wang, T., Cui, Y., Zhang, B., Shang, D., & Song, H. (2025) · Discover Oncology · doi:10.1007/s12672-025-03679-6 · Cited by 1
Cancer-Associated Fibroblasts: Heterogeneity and Bimodality in Oncogenesis
Lunina, N. A., Safina, D. R., & Kostrov, S. V. (2023) · Molecular Biology · doi:10.1134/s0026893323050096 · Cited by 1
Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma
Kantheti, H. S., Hale, M. A., Choudhuri, S. P., Huang, H., Wang, X., Zolghadri, Y., Innamorati, G., Manikonda, S. P. R., Reddy, N. R., Reddy, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126619 · Cited by 1
Self-citationJost, P. J., Weindl, D., Wunderling, K., Thiele, C., & Hasenauer, J. (2026) · iScience · doi:10.1016/j.isci.2026.115474 · Cited by 1
Li, W., Jihad, M., Lloyd, E. G., Zaccaria, M., Mucciolo, G., Nsubuga, G., Koonan-Lonappan, A., Henríquez, J. A., Cheng, P. S. W., Harish, S., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-02057-w · Cited by 1
Autophagy in cancer-associated fibroblasts: biology and targeting
Ly, T., Gaur, G., & Thomas, S. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99879-6.00004-3 · Cited by 1
Sun, J., Lu, P., Guan, S., & Liu, S. (2023) · PubMed Central · doi:10.12122/j.issn.1673-4254.2023.09.14 · Cited by 1
Vitamin D and pancreatic cancer
de Maturana, E. L., Zagorac, S., Malats, N., & Real, F. X. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91338-6.00042-2 · Cited by 1
NEVE, B. P., Jonckheere, N., Vincent, A., & SEUNINGEN, I. V. (2020) · RNA technologies · doi:10.1007/978-3-030-44743-4_9 · Cited by 1
Genetic landscape of prognostic value in pancreas ductal adenocarcinoma microenvironment—reply
Pu, N., Yu, J., & Wu, W. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.04.30 · Cited by 1
Jacob, H. K. C., Lavania, S., & Saluja, A. K. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.028 · Cited by 1
Langer, E. M., Farrell, A. S., Allen-Petersen, B. L., Daniel, C. J., Kresse, K., English, I., Shah, V. M., MacPherson, K. A., Wang, X., Pelz, C., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3800381
ecDNA-driven oncogene super-expressors shape immunoevasive tumor microenvironmentPreprint
Qiao, K., Yang, Q., Li, T., Chen, X., Yazgan, Z., Kim, Y. J., Gilbreath, C., Lim, J. Y. S., Xie, Y., Sun, X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.15.688565 · Cited by 1
Self-citationLocal glucocorticoid signalling promotes pancreatic cancerPreprint
Veiga-Villauriz, C., Hussein, H. A. M., Ward, C. J., Saji, S. K., Chakraborty, S., Pramanik, J., Yamashita-Kanemaru, Y., Simpson, J. P., Laforest, S., Diez, F., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.14.688472 · Cited by 1
The Japan Kibbutz Association.
Altman, A. A. (1970)
Tracing back to one of the origins of immune evasion in pancreatic cancer
Henríquez, J. A., & Biffi, G. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.05.002
Transcriptionally defined morphological subtypes of pancreatic ductal adenocarcinomaPreprint
Krieger, T. G., Sudy, A., Schicktanz, F., Tosti, L., Liebig, J., Konukiewitz, B., Rouault, M., Niesnerova, A., Qian, X., Weichert, W., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.23.509133
Gopalan, V., Singh, A., Mehrabadi, F. R., Wang, L., Ruppin, E., Arda, H. E., & Hannenhalli, S. S. (2023) · doi:10.1158/0008-5472.c.6512943.v1
Carpenter, E. S., Elhossiny, A. M., Kadiyala, P., Li, J., McGue, J. J., Griffith, B. D., Zhang, Y., Edwards, J., Nelson, S., Lima, F., et al. (2023) · doi:10.1158/2159-8290.c.6651113
Self-citationKishore, U., Varghese, P. M., Mangogna, A., Klein, L., Tu, M., Urbach, L., Qiu, M., Nicolle, R., Murugaiah, V., Beirag, N., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.28.564512
Single-Cell RNA Sequencing: A Deep Dive into The Cellular Landscape and Interactions in Osteosarcoma
Zheng, S. (2023) · Transactions on Materials Biotechnology and Life Sciences · doi:10.62051/91yqvp26
Zhang, A. M. Y., Chu, K., Daly, B. F., Ruiter, T. J. J., Dou, Y., Yang, J. C. C., de Winter, T. J. J., Chhuor, J., Wang, S., Flibotte, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19211339
Comparison of Different Approaches to Single Cell RNA Sequencing of Cancer Associated FibroblastsPreprint
Kung, H., Loycano, M., Zheng, L., Chen, S. Y., & Zimmerman, J. W. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.29.591011
Gupta, M., Choi, H., Furth, E. E., Shaffer, S. M., Pickup, S., Clendenin, C., Liu, F., Cao, Q., Song, H. K., Yong Fan, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.24.630138
Zhang, A. M. Y., Chu, K., Daly, B. F., Ruiter, T. J. J., Dou, Y., Yang, J. C. C., de Winter, T. J. J., Chhuor, J., Wang, S., Flibotte, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19211348
Zhang, A. M. Y., Chu, K., Daly, B. F., Ruiter, T. J. J., Dou, Y., Yang, J. C. C., de Winter, T. J. J., Chhuor, J., Wang, S., Flibotte, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19211351
Zhang, A. M. Y., Chu, K., Daly, B. F., Ruiter, T. J. J., Dou, Y., Yang, J. C. C., de Winter, T. J. J., Chhuor, J., Wang, S., Flibotte, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19211336
Zhang, A. M. Y., Chu, K., Daly, B. F., Ruiter, T. J. J., Dou, Y., Yang, J. C. C., de Winter, T. J. J., Chhuor, J., Wang, S., Flibotte, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19211345
A macrophage-derived noncanonical WNT niche drives immune exclusion in pancreatic cancerPreprint
Kim, N. H., Song, Y. M., Kwon, S. S., Lee, S. H., Kim, E. N., Hong, J. J., Seok, S. H., & Na, Y. R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.05.704114
Stromal cells in mammary gland development and cancer
Benabid, A. (2020) · theses.fr (ABES) · doi:10.70675/8612698bz63e1z401eza0caz2b4d989c570f
Role of the stromal microenvironment in PDAC and resistance to therapies
Ode, A. (2024) · theses.fr (ABES) · doi:10.70675/0452e0e9z98e8z47d9za007zd4b472926aab
Meledathu, S., Chennareddy, S., Naidu, M. P., Meehan, S. A., Aðalsteinsson, J. A., Alkon, N., Cohenour, E. R., Christensen, G., Port, L. R., Fleischli, A., et al. (2026) · Blood Advances · doi:10.1182/bloodadvances.2025017533
Shah, N., Quaye, M. B., Sudula, B., Kulkarni, N., Upreti, A., Malkoochi, A., Aileni, T. R., Karambelkar, K., Peterson, A., Mahmoud, D., et al. (2026) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-026-00909-w
Self-citationYan, X., Xu, H.-Y., Liu, J.-W., Yang, Z.-Y., & Zhu, Q. (2026) · World Journal of Clinical Oncology · doi:10.5306/wjco.v17.i5.119864
CA19-9 induces microenvironment remodeling in pancreatic ductal adenocarcinomaPreprint
Hsu, J., Song, H., Ogawa, S., Kubota, C. S., Peck, K. L., Jacobs, E., Garcia-Rivera, L., Zhu, J., Sui, Y., Jung, W., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.727290
Zoi, I., Rajput, M., Holguín-Horcajo, A., Haidar, M., Brusa, D., Chu, K., Xie, J., Shields, M. A., Ferreira, S., Stanger, B. Z., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218666
RNA methyltransferase 3 drives pancreatic acinar cell carcinoma growth and is a therapeutic target
Tatekawa, S., Hara, T., Meng, S., Sato, T., Arai, T., Tamari, K., Arao, Y., Tsuji, Y., Konno, M., Ofusa, K., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02880-5
Treffert, S. M., Heneka, Y. M., Martin, J., Gargano, A., Launhardt, L., Akilli‐Öztürk, Ö., Stanganello, E., Andrieux, G., Hoch, D., Sonnentag, S. J., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-09155-5
Zhou, Y., Guo, S., Zhou, W., & Wang, W. (2026) · Cells · doi:10.3390/cells15201844
Subtype or state? Rethinking the apCAF paradox and fibroblast plasticity in gastrointestinal cancers
Yu, Z., Hu, D., & An, Z. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.2000409
MUC16 drives macrophage-mediated immunosuppression in pancreatic cancer
Rajesh, C., Sagar, S., Huang, Y., Mundry, C. S., Chaitankar, V., Shah, O. S., Sumeet, C., Caffrey, T., O’Connell, K. A., Swanson, B., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218927
Erreni, M., Fumagalli, M. R., D’Anna, R., Sollai, M., Bozzarelli, S., Nappo, G., Zanini, D., Parente, R., Garlanda, C., Rimassa, L., et al. (2025) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.15005984
Gu, G., Du, Y., Zhang, H., Zheng, Y., Yanjun, Y., & Yan, Q. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1968254
Metadata
- Authors
- Hosein, A. N., Huang, H., Wang, Z., Parmar, K., Du, W., Huang, J., Maitra, A., Olson, E., Verma, U., & Brekken, R. A.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Brekken, Rolf A.
- ORCID
- Venue
- JCI Insight
- Published
- 2019-08-22
- Volume
- 4
- Issue
- 16
- ISSN
- 2379-3708 (ISSN-L)
- PMC
- PMC6777805
- OpenAlex
- W2964097765
- Cited by
- 302
- References
- 58
- Citations by year
- 2026: 22 · 2025: 29 · 2024: 41 · 2023: 64 · 2022: 61 · 2021: 41 · 2020: 39 · 2019: 4
- FWCI
- 15.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- JCI Insight (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Texas Southwestern Medical Center (See comments)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- pancreatic ductal adenocarcinoma, tumor progression, cellular heterogeneity, epithelial-mesenchymal transition, tumor-associated macrophages, tumor-infiltrating fibroblasts, fibroblast heterogeneity, tumor microenvironment, epigenetic regulation, genetically engineered mouse models, tumor heterogeneity, stromal heterogeneity
- MeSH terms
- Animals, Disease Models, Animal, Fibroblasts, Mice, Inbred C57BL, Mutation, Pancreatic Neoplasms, Gene Expression Regulation, Neoplastic, Sequence Analysis, Genetic Heterogeneity, Genetic Predisposition to Disease, Carcinoma, Pancreatic Ductal, Mice, Epigenomics, Single-Cell Analysis, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review